DYN
Dyne Therapeutics, Inc.
Industry
Biotechnology
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
Loading...
Open
29.29
Mkt cap
2.9B
Volume
1.2M
High
29.52
P/E Ratio
-7.96
52-wk high
47.45
Low
28.14
Div yield
N/A
52-wk low
8.04

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.